Markets 

J&J says delaying rollout of COVID-19 vaccine in Europe

FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – Johnson & Johnson said on Tuesday it would delay the rollout of its COVID-19 vaccine in Europe and was reviewing cases of extremely rare blood clots in people after they received the shot with European health authorities.

U.S. federal health agencies on Tuesday recommended pausing the use of the COVID-19 vaccine as six women under 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic. (bit.ly/3tf2s85)

Source: Read Full Article

You May Also Like

Asia shares spooked by U.S. inflation scare, hope for Fed calm

New York City to require COVID-19 vaccinations for all public employees – WSJ

AT&T close to deal to combine media empire with Discovery-reports